Back to Journals » Vascular Health and Risk Management » Volume 8

Corrigendum

Authors De Caterina A, Harper A, Cuculi

Received 26 June 2012

Accepted for publication 26 June 2012

Published 19 July 2012 Volume 2012:8 Pages 443—445

DOI https://doi.org/10.2147/VHRM.S35364


De Caterina AR, Harper AR, Cuculi F. Critical evaluation of the efficacy and tolerability of azilsartan. Vasc Health Risk Manag. 2012;8:299–305.
Some data were presented incorrectly in the published version of Table 1.
Read the original article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]